@prefix cas: <http://identifiers.org/cas/> .
@prefix dcterms1: <http://purl.org/dc/terms> .
@prefix inchikey: <http://identifiers.org/inchikey/> .
@prefix massbank: <https://identifiers.org/massbank/> .
@prefix mbo: <http://www.massbank.jp/ontology/> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix schema: <https://schema.org/> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

massbank:MSBNK-BAFG-CSL23111010021 a mbo:MassSpectrum ;
    dcterms1:creator "Kevin S. Jewell; Bj√∂rn Ehlig; Arne Wick" ;
    dcterms1:date "2023-11-10"^^xsd:date ;
    dcterms1:identifier "MSBNK-BAFG-CSL23111010021" ;
    dcterms1:license <https://creativecommons.org/licenses/by-sa/4.0/> ;
    dcterms1:rights "Copyright 2023 Federal Institute of Hydrology, Koblenz, Germany under dl-de/by-2-0" ;
    mbo:analytical_methods_and_conditions [ a mbo:AnalyticalMethods ;
            mbo:ac_instrument "TripleTOF 5600 SCIEX" ;
            mbo:collision_energy "100" ;
            mbo:column_name "Zorbax Eclipse Plus C18 2.1 mm x 150 mm, 3.5 um, Agilent" ;
            mbo:flow_gradient "0 min min 98% A, 1 min 98% A, 2 min 80% A, 16.5 min 2% A, 22 min 2% A, 22.1 min 98% A, 27 min 98% A" ;
            mbo:flow_rate "0.3 mL/min" ;
            mbo:fragmentation_mode "CID" ;
            mbo:instrument_type "LC-ESI-QTOF" ;
            mbo:ion_mode "POSITIVE" ;
            mbo:ms_type "MS2" ;
            mbo:retention_time "6.261 min" ;
            mbo:solvent "A: Water 0.1% Formic acid, B: Acetonitrile 0.1% Formic acid" ] ;
    mbo:compound [ a schema:chemicalsubstance ;
            mbo:ch_compound_class "Antimicrobial; Pharmaceutical" ;
            mbo:ch_exact_mass 4.241799e+02 ;
            rdfs:name "Clindamycin" ;
            rdfs:seeAlso cas:18323-44-9 ;
            schema:inChI "InChI=1S/C18H33ClN2O5S/c1-5-6-10-7-11(21(3)8-10)17(25)20-12(9(2)19)16-14(23)13(22)15(24)18(26-16)27-4/h9-16,18,22-24H,5-8H2,1-4H3,(H,20,25)" ;
            schema:inChIKey inchikey:KDLRVYVGXIQJDK-UHFFFAOYSA-N ;
            schema:molecularFormula "C18H33ClN2O5S" ;
            schema:name "Clindamycin" ;
            schema:smiles "CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)Cl" ] ;
    mbo:has_peak [ mbo:intensity 1.2e+01 ;
            mbo:mz 4.20473e+01 ;
            mbo:peak_sequential_number 1 ;
            mbo:relative_intensity 114 ],
        [ mbo:intensity 3.85e+01 ;
            mbo:mz 8.20685e+01 ;
            mbo:peak_sequential_number 10 ;
            mbo:relative_intensity 367 ],
        [ mbo:intensity 2.23e+01 ;
            mbo:mz 8.30759e+01 ;
            mbo:peak_sequential_number 11 ;
            mbo:relative_intensity 213 ],
        [ mbo:intensity 5.7e+00 ;
            mbo:mz 8.40842e+01 ;
            mbo:peak_sequential_number 12 ;
            mbo:relative_intensity 54 ],
        [ mbo:intensity 1.1e+00 ;
            mbo:mz 9.30712e+01 ;
            mbo:peak_sequential_number 13 ;
            mbo:relative_intensity 10 ],
        [ mbo:intensity 2.5e+00 ;
            mbo:mz 9.50874e+01 ;
            mbo:peak_sequential_number 14 ;
            mbo:relative_intensity 24 ],
        [ mbo:intensity 6.7e+00 ;
            mbo:mz 9.60823e+01 ;
            mbo:peak_sequential_number 15 ;
            mbo:relative_intensity 64 ],
        [ mbo:intensity 3.8e+00 ;
            mbo:mz 9.70889e+01 ;
            mbo:peak_sequential_number 16 ;
            mbo:relative_intensity 36 ],
        [ mbo:intensity 1.3e+00 ;
            mbo:mz 9.8097e+01 ;
            mbo:peak_sequential_number 17 ;
            mbo:relative_intensity 12 ],
        [ mbo:intensity 5.1e+00 ;
            mbo:mz 1.241126e+02 ;
            mbo:peak_sequential_number 18 ;
            mbo:relative_intensity 49 ],
        [ mbo:intensity 1.048e+02 ;
            mbo:mz 1.261279e+02 ;
            mbo:peak_sequential_number 19 ;
            mbo:relative_intensity 999 ],
        [ mbo:intensity 3e+00 ;
            mbo:mz 4.40601e+01 ;
            mbo:peak_sequential_number 2 ;
            mbo:relative_intensity 29 ],
        [ mbo:intensity 1.1e+00 ;
            mbo:mz 5.60573e+01 ;
            mbo:peak_sequential_number 3 ;
            mbo:relative_intensity 10 ],
        [ mbo:intensity 2.6e+00 ;
            mbo:mz 5.80725e+01 ;
            mbo:peak_sequential_number 4 ;
            mbo:relative_intensity 25 ],
        [ mbo:intensity 1.2e+00 ;
            mbo:mz 6.70462e+01 ;
            mbo:peak_sequential_number 5 ;
            mbo:relative_intensity 11 ],
        [ mbo:intensity 4.2e+00 ;
            mbo:mz 6.70577e+01 ;
            mbo:peak_sequential_number 6 ;
            mbo:relative_intensity 40 ],
        [ mbo:intensity 1.12e+01 ;
            mbo:mz 6.80557e+01 ;
            mbo:peak_sequential_number 7 ;
            mbo:relative_intensity 107 ],
        [ mbo:intensity 1.03e+01 ;
            mbo:mz 6.9075e+01 ;
            mbo:peak_sequential_number 8 ;
            mbo:relative_intensity 98 ],
        [ mbo:intensity 2.33e+01 ;
            mbo:mz 7.00705e+01 ;
            mbo:peak_sequential_number 9 ;
            mbo:relative_intensity 222 ] ;
    mbo:mass_spectram_meta_data [ a mbo:MassSpectramMetaData ;
            mbo:precursor_mz 4.251871e+02 ;
            mbo:precursor_type mbo:IT003 ] ;
    mbo:pk_num_peak 19 ;
    mbo:pk_splash "splash10-0059-9600000000-03706ce146146e312d8f" ;
    rdfs:comment "Acquisition method: 10.1002/rcm.8541" ;
    skos:definition "Clindamycin; LC-ESI-QTOF; MS2; 100 V" .

